This move is archived. Current quotes and coverage live on the stock page.
Get EXE alerts:
Extendicare Inc faces a notable decline in its stock price, raising concerns for investors.
On the TSX, Extendicare Inc (EXE.TO) experienced a drop of 2.25% in the last trading session, closing at CA$32.61. This decline comes amid broader market movements and specific company challenges that may be affecting investor confidence.
Investor takeaway: Investors should closely monitor Extendicare's performance and consider the implications of recent market trends and company news on its future prospects.
Advertisement
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
WealthAwesomeMarket cap
$2.95B
P/E
23.7x
Div. yield
1.65%
Div. / share
$0.51
52W high
$39.04
52W low
$12.74
1W change
-0.48%
Beta
1.11
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 28.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$39.83
+28.5% Upside
Current Price
C$31.01
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
33.9%
Annualized
90-Day Vol
36.6%
Annualized
Trend (90d)
-26.4%
Annualized drift
90d Mean
C$28.22
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$30.05 | C$26.73 โ C$33.78 |
| 60 trading days | C$29.12 | C$24.68 โ C$34.36 |
| 90 trading days | C$28.22 | C$23.05 โ C$34.56 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
2.25% Decline in Stock Price
Extendicare's stock has dropped to CA$32.61, indicating investor concerns that may affect future performance.
Bull case
Despite today's setback, Extendicare has a solid market cap of CA$3.13 billion and a profit margin of 6.99%. This suggests thereโs potential for recovery if the healthcare sector rebounds.
Bear case
The recent slide could signal underlying issues within the company or sector, especially as it faces increasing scrutiny in a competitive healthcare market.
Market Reaction
Advertisement
The 2.25% drop in Extendicare's stock price reflects investor sentiment, influenced by recent news in the healthcare sector. As the company prepares for its inclusion in the S&P/TSX Composite Index, investors are cautious about potential volatility and the implications of broader market trends.
Company Fundamentals
With a P/E ratio of 24.24 and a profit margin of 6.99%, Extendicare's fundamentals suggest growth potential. However, the recent decline raises questions about its ability to maintain performance amid changing market conditions. Investors should assess whether the current price is a buying opportunity or a warning sign.
Looking Ahead
As Extendicare Inc navigates these challenges, investors should keep an eye on upcoming earnings reports and industry developments. The healthcare sector is known for its resilience, but any shifts in policy or market dynamics could significantly impact Extendicare's trajectory. For more insights on EXE.TO, check out our detailed analysis here.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
